Emergency department contribution to HCV elimination in the Iberian Peninsula

Emergency department contribution to HCV elimination in the Iberian Peninsula

Abstract Background Undiagnosed cases of hepatitis C virus (HCV) infection result in significant morbidity and mortality, further transmission, and increased public health costs. Testing in emergency departments (EDs) is an opportunity to expand HCV screening. The goal of this project was to increas...

Descripció completa

Dades bibliogràfiques
Autors principals:	Maria Buti, Inês Vaz-Pinto, Vítor Magno Pereira, Marta Casado, Jordi Llaneras, Ana Barreira, Catarina Esteves, Mafalda Guimarães, Ana Gorgulho, Tomás Mourão, Elisa Xavier, Luís Jasmins, Ana Paula Reis, Nancy Faria, Bruno Freitas, Graça Andrade, Anny Camelo-Castillo, Manuel Ángel Rodríguez-Maresca, Alba Carrodeguas, Diogo Medina, Rafael Esteban
Format:	Article
Idioma:	English
Publicat:	BMC 2024-01-01
Col·lecció:	International Journal of Emergency Medicine
Matèries:	HCV Emergency department Screening Diagnosis
Accés en línia:	https://doi.org/10.1186/s12245-023-00570-5

Ítems similars

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
per: Wei-Ming Chen, et al.
Publicat: (2021-05-01)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
per: Ashfaq Usman Alli A, et al.
Publicat: (2011-06-01)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
per: Rujipat Wasitthankasem, et al.
Publicat: (2017-11-01)

Hepatitis C virus quantification in serum and saliva of HCV-infected patients
per: Gisele Barreto Lopes Menezes, et al.
Publicat: (2012-08-01)

Distribution of HCV genotypes among different exposure categories in Brazil
per: Oliveira M.L.A., et al.
Publicat: (1999-01-01)

Diagnostic accuracy of a new commercially available HCV-antigen test
per: Marta Monari, et al.
Publicat: (2010-03-01)

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience
per: Andrea Marino, et al.
Publicat: (2021-12-01)

The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients
per: Tuğrul Himmetoğlu, et al.
Publicat: (2007-07-01)

An overview of HCV molecular biology, replication and immune responses
per: Nawaz Zafar, et al.
Publicat: (2011-04-01)

Most common HCV genotypes in patients from north-eastern Croatia
per: Magdalena Perić, et al.
Publicat: (2014-05-01)

HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
per: Mahantesh B Nagamoti, et al.
Publicat: (2018-04-01)

A retrospective study to find the prevalence of HIV, HCV and dual HIV-HCV infection in the prison inmates
per: Gur Parkash Singh, et al.
Publicat: (2022-01-01)

Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico
per: Ana María Rivas-Estilla, et al.
Publicat: (2008-04-01)

HIV, HCV and HIV-HCV Coinfections in the General Population versus Inmates from Romania
per: Camelia Sultana, et al.
Publicat: (2024-08-01)

Sieroprevalenza di infezione da HBV e HCV tra pazienti in dialisi
per: Rosa Anna Leone, et al.
Publicat: (2003-12-01)

Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity
per: Ana C. Maretti-Mira, et al.
Publicat: (2023-06-01)

Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile
per: Emiliano Dalla, et al.
Publicat: (2022-02-01)

Assessment of HCV Infection in Suspected Orphans Newborns by Real-Time PCR and HCV-Core Ag-Elisa
per: Marzieh Jamalidoust, et al.
Publicat: (2015-08-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
per: Ana Virseda-Berdices, et al.
Publicat: (2025-01-01)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
per: Óscar Brochado, et al.
Publicat: (2021-03-01)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
per: Martina Spaziante, et al.
Publicat: (2021-07-01)

Prevalenza dei genotipi di HCV nella Sicilia centro-meridionale
per: Liborio Bellomo, et al.
Publicat: (2003-03-01)

Effect of HCV on lipids profile of HIV patients
per: Mehrnaz Rasoolinejad, et al.
Publicat: (2011-12-01)

Effect of HCV on lipids profile of HIV patients
per: Mehrnaz Rasoolinejad, et al.
Publicat: (2012-02-01)

Time and Mode of Epidemic HCV-2 Subtypes Spreading in Europe: Phylodynamics in Italy and Albania
per: Erika Ebranati, et al.
Publicat: (2021-02-01)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
per: Truong Tam Nguyen, et al.
Publicat: (2018-12-01)

Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors
per: Felicidade Mota Pereira, et al.
Publicat: (2014-01-01)

Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention
per: Inês Vaz-Pinto, et al.
Publicat: (2024-01-01)

Treatment of Chronic HCV Infection in Special Populations
Publicat: (2006-04-01)

Prevalence of Hepatitis C Virus (HCV) Genotypes in Rawalpindi and Islamabad Region
per: Andleeb Afzal
Publicat: (2017-06-01)

HCV Co-Infection and Its Genotypic Distribution in HIV-Infected Patients in Nepalese Population
per: Uday Kant Sah, et al.
Publicat: (2023-07-01)

Elimination of HCV in Russia: Barriers and Perspective
per: Vasily Isakov, et al.
Publicat: (2022-04-01)

Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years
per: Pietro Torre, et al.
Publicat: (2024-11-01)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
per: Claudia Minosse, et al.
Publicat: (2021-06-01)

Dried blood spot as alternative specimen for molecular epidemiology studies among HCV/HIV coinfected patients
per: Geane Flores, et al.
Publicat: (2025-03-01)

HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination
per: Christos Thomadakis, et al.
Publicat: (2024-05-01)

Molecular Evaluation of Viral load and Genotype of HCV in Acute and Chronic HCV Patients in Kirkuk City
per: Israa Saadoon, et al.
Publicat: (2019-03-01)

Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil
per: M.L.A. Oliveira, et al.
Publicat: (1999-09-01)

Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
per: Fatih Mehmet Akıllı
Publicat: (2024-12-01)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
per: Shrikant Dasharath Warkad, et al.
Publicat: (2018-07-01)